Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies

Viral diseases represent a major public health concerns and ever-present risks for developing into future pandemics. Antiviral antibody therapeutics, either alone or in combination with other therapies, emerged as valuable preventative and treatment options, including during global emergencies. Here...

Full description

Bibliographic Details
Main Authors:	Evi B. Struble, Jonathan M. O. Rawson, Tzanko Stantchev, Dorothy Scott, Marjorie A. Shapiro
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Pharmaceutics
Subjects:	antiviral therapy antiviral antibodies antibody combination therapy antibody potency potency assays
Online Access:	https://www.mdpi.com/1999-4923/15/5/1538

Similar Items

Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies
by: Brady T. Hickerson, et al.
Published: (2023-08-01)

Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
by: Ames C. Register, et al.
Published: (2021-05-01)

Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
by: Osnat Rosen, et al.
Published: (2016-09-01)

Role of Homologous Fc Fragment in the Potency and Efficacy of Anti‐Botulinum Antibody Preparations
by: Amram Torgeman, et al.
Published: (2017-05-01)

Development of a mechanism of action-reflective, dual target cell-based reporter bioassay for a bispecific monoclonal antibody targeting human CTLA-4 and PD-1
by: Weimin Chen, et al.
Published: (2021-01-01)

Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
by: Kartik Narayan, et al.
Published: (2023-06-01)

Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
by: Madhu S. Pandey, et al.
Published: (2021-10-01)

HIV-1 bispecific antibody iMab-N6 exhibits enhanced breadth but not potency over its parental antibodies iMab and N6
by: Tumelo Moshoette, et al.
Published: (2022-09-01)

THE LEVEL OF ANTIVIRAL ANTIBODIES AND INDEXES OF LOCAL IMMUNITY INTHE DYNAMICS OF THE TREATMENT OF CHILDREN WITH GLOMERULONEPHRITIS IN THE PRESENCE OF HERPESVIRAL INFECTION
by: V. Kruglikov, et al.
Published: (2016-08-01)

Progress in drug therapy for COVID-19 infection
by: LIU Fang-yuan, SU Xiu-lan
Published: (2020-10-01)

A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody
by: Sunil Gairola, et al.
Published: (2020-08-01)

Comparative evaluation of mono- and polyclonal antibodies used in identification of interferon alpha-2b products
by: L. A. Gayderova, et al.
Published: (2021-03-01)

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
by: Andrew Tung Yep, et al.
Published: (2021-03-01)

Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
by: Matthew Zirui Tay, et al.
Published: (2019-02-01)

Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines
by: Nisarg Patel, et al.
Published: (2023-07-01)

Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects
by: Dhuha H Nawab
Published: (2021-12-01)

Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play
by: Jennifer Lambour, et al.
Published: (2016-01-01)

Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017-04-01)

In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
by: Silvere Pagant, et al.
Published: (2021-11-01)

Specific humoral immunity after immunization with vaccine contained Leningrad-3 (L-3) mumps virus strain of different potency
by: E. V. Оtmshevskaya, et al.
Published: (2019-08-01)

Preparation of polyclonal and monoclonal anti-idiotypic antibodies against morphine-specific immunoglobulins
by: A. V. Trofimov, et al.
Published: (2020-01-01)

PREPARATION AND PROPERTIES OF MURINE ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES RECOGNIZING PRIMARY RABBIT POLYCLONAL ANTIBODIES AGAINST MORPHINE DERIVATIVES
by: A. V. Trofimov, et al.
Published: (2019-12-01)

Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction
by: Fabian Bickel, et al.
Published: (2023-12-01)

Fc-Dependent Immunomodulation Induced by Antiviral Therapeutic Antibodies: New Perspectives for Eliciting Protective Immune Responses
by: Mireia Pelegrin, et al.
Published: (2022-07-01)

Monoclonal antibody against EV71 3Dpol inhibits the polymerase activity of RdRp and virus replication
by: Yaoming Li, et al.
Published: (2019-01-01)

Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays
by: Xuanxuan Zhang, et al.
Published: (2023-12-01)

Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy
by: Mar Naranjo-Gomez, et al.
Published: (2021-02-01)

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines
by: Jesse Bodle, et al.
Published: (2023-03-01)

Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
by: Oana Săndulescu, et al.
Published: (2023-03-01)

Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling
by: Iftekhar Mahmood
Published: (2020-08-01)

Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?
by: Cassandra M. Berry
Published: (2018-03-01)

A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease
by: Dirk Bauer, et al.
Published: (2017-10-01)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
by: Bronwyn M. Gunn, et al.
Published: (2021-11-01)

Antiviral Agents
by: Firdevs AKTAŞ
Published: (1997-12-01)

A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
by: Jun-Gyu Park, et al.
Published: (2020-02-01)

Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
by: Leonor Kremer, et al.
Published: (2018-03-01)

Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
by: Giuseppe A. Ramirez, et al.
Published: (2023-08-01)

Monoclonal and polyclonal antibodies for ante- and post-mortem detection of PrPSc in sheep
by: Michele Dietrich Moura Costa, et al.
Published: (2015-04-01)

Plant-Based Drugs and Vaccines for COVID-19
by: Nasir Mahmood, et al.
Published: (2020-12-01)

Establishment of the 1st Chinese national standard for CA6 neutralizing antibody
by: Yiping Wang, et al.
Published: (2023-01-01)